The Patent Finder

Jiangsu Simcere Pharmaceutical R&D Co., Ltd.

Also on record
Records under this name other than patents Jiangsu Simcere Pharmaceutical R&D Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Jiangsu Simcere Pharmaceutical R&D Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,084,6213-Pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,658,684Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,986,692Anti-VEGF Monoclonal Antibody and Pharmaceutical Composition Comprising Said Antibody
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,018,242Salt Form of Tyrosine Kinase Inhibitor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,802,824Modified Recombinant Human Endostatin and Uses Thereof
Formerly held
Lapsed on the fee record
Ended Aug 12, 2026 · High confidence
Lapsed on the fee recordEnded Aug 12, 2026High confidence
US 7,008,921Materials and methods relating to endothelial cell growth inhibitors
Lapsed on the fee record
Ended Mar 7, 2014 · USPTO record
Lapsed on the fee recordEnded Mar 7, 2014USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited